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Abstract
Broiler chickens are rather resistant to deoxynivalenol and thus, clinical signs are rarely seen. However, effects of subclinical
concentrations of deoxynivalenol on both the intestine and the liver are less frequently studied at the molecular level.
During our study, we investigated the effects of three weeks of feeding deoxynivalenol on the gut wall morphology,
intestinal barrier function and inflammation in broiler chickens. In addition, oxidative stress was evaluated in both the liver
and intestine. Besides, the effect of a clay-based mycotoxin adsorbing agent on these different aspects was also studied. Our
results show that feeding deoxynivalenol affects the gut wall morphology both in duodenum and jejenum of broiler
chickens. A qRT-PCR analysis revealed that deoxynivalenol acts in a very specific way on the intestinal barrier, since only an
up-regulation in mRNA expression of claudin 5 in jejunum was observed, while no effects were seen on claudin 1, zona
occludens 1 and 2. Addition of an adsorbing agent resulted in an up-regulation of all the investigated genes coding for the
intestinal barrier in the ileum. Up-regulation of Toll-like receptor 4 and two markers of oxidative stress (heme-oxigenase or
HMOX and xanthine oxidoreductase or XOR) were mainly seen in the jejunum and to a lesser extent in the ileum in response
to deoxynivalenol, while in combination with an adsorbing agent main effect was seen in the ileum. These results suggest
that an adsorbing agent may lead to higher concentrations of deoxynivalenol in the more distal parts of the small intestine.
In the liver, XOR was up-regulated due to DON exposure. HMOX and HIF-1a (hypoxia-inducible factor 1a) were down-
regulated due to feeding DON but also due to feeding the adsorbing agent alone or in combination with DON.
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Introduction
Mycotoxin contamination can occur in all agricultural com-
modities in the field and/or during storage, if the conditions are
favorable for fungi growth [1]. Deoxynivalenol (DON), also called
vomitoxin, is a trichothecene mycotoxin which is highly prevalent
in Europe [2–4]. In poultry, DON rarely causes acute mycotox-
icosis. However, chronic exposure to the toxin can lead to reduced
production and an altered immune function [5]. As poultry seems
to be less susceptible to DON-mycotoxicosis compared to other
animals, infected cereal batches are sometimes diverted to the
poultry feed production [6]. Mycotoxin-detoxifying agents are
frequently used feed additives to reduce the adverse effects of
mycotoxins. Detoxifiers based on clay minerals are classified by
the European Food Safety Authority (EFSA) as adsorbing agents
[7].
Mycotoxins are food and feed contaminants and thus after
ingestion the intestine can be exposed to high concentrations of the
toxins [8,9]. The epithelial surface of the intestine is characterized
by a large contact area for absorption of nutrients and xenobiotics.
This surface consists of a simple columnar epithelium, which is
increased by the presence of villi [10]. Both toxins and mycotoxin
detoxifiers can interact with this surface area, resulting in altered
extent and rate of absorption of xenobiotics such as drugs and
mycotoxins. For example, we found in a previous study higher
plasma concentrations of DON in animals fed contaminated feed
in combination with a clay-based adsorbing agent compared to
animals fed DON contaminated feed only [11,12].
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The absorbing epithelial cells (enterocytes) are connected
strongly by tight junction proteins. These tight junctions seal off
the luminal end of the intercellular space and so transport by this
paracellular route is very limited [13].
Claudins are transmembrane proteins which form the backbone
of the tight junction strands. Claudin 1 and 5 are known to interact
and are important to guarantee the intestinal barrier function.
Both claudins have already been characterized in chickens [14–
16]. The family of zona occludens, including zona occludens 1
(ZO 1) and zona occludens 2 (ZO 2), is a group of scaffolding
proteins which is part of the cytoplasmic plaque of the tight
junctions.
The intestinal epithelial cells also contribute to the regulation of
inflammatory conditions and create a kind of barrier against
invading pathogens. Toll-like receptors (TLR) in the intestinal
epithelium, particularly TLR4, serve as rapid pathogen sensors.
After intestinal absorption of mycotoxins these compounds
reach the liver as the gateway of the portal blood draining the
gastrointestinal tract. Both intestine and liver consist of rapidly
proliferating cells and have a high protein turnover rate.
Therefore, we may suppose that these organs are more sensitive
for the action of DON [17].
The toxicity of DON is mediated by various mechanisms.
Trichothecenes are potent inhibitors of the RNA, DNA and
protein synthesis [18]. In addition, DON may induce the
production of free radicals and cellular oxidative stress. It has
been shown that oxidative stress causes up-regulation of hypoxia-
inducible factor 1, subunit alpha (HIF-1a) [19], a transcription
factor which regulates genes involved in inflammation and cell
death [20]. Heme-oxigenase (HMOX) is another sensitive marker
of oxidative injury, which affords protection against hepatocyte
death [21]. Both HIF-1a and HMOX have already been
characterized in chickens [22,23]. Xanthine oxidoreductase
(XOR) is an enzyme associated with the synthesis of reactive
oxygen species and is part of the cellular defense enzyme systems
[24]. In broilers, this enzyme is mainly expressed in the liver, but
also in the intestine (60% of the amount in the liver) and other
organs but in a lower amount [25]. The intestine requires an
efficient immune defense at the epithelial surface, and among
other factors, XOR is secreted by the enterocytes of the small
intestine [26].
The aim of our study was to assess the effects of three weeks
dietary exposure to DON on the small intestine and liver in broiler
chickens. To this end qRT-PCR analyses were conducted to study
if genes coding for oxidative stress and inflammation response are
influenced by DON, both in the liver and the small intestine. In
addition, the effects of DON on the intestinal morphology and
intestinal barrier function were investigated with histopathology
and qRT-PCR analysis, respectively. To our knowledge, this is the
first in vivo study which observes these parameters in broiler
chickens. Finally, the effects of a clay-based mycotoxin-detoxifying
agent were also investigated during our trial.
Materials and Methods
Ethics Statement
The protocol was approved by the Ethical Committee of the
Faculty of Veterinary Medicine (Ghent University) (EC 2010/064
and EC 2010/076). All husbandry practices and euthanasia were
performed with full consideration of animal welfare.
Animals and Diets
The animals and the experimental design have been described
elsewhere [12]. In brief, 32 1-day-old broiler chickens were fed
uncontaminated feed during an acclimatization period of ten days.
Afterwards, the animals were divided into four different dietary
groups of 8 animals each: a control group receiving uncontam-
inated feed, a group receiving uncontaminated feed+adsorbing
agent, a third group receiving naturally DON contaminated feed
and a group fed naturally DON contaminated feed+adsorbing
agent. Analyses of the feed were performed by a multi-mycotoxin
LC-MS/MS method [3]. The naturally contaminated feed was
contaminated as follows: DON (7.54062.20 mg/kg), 3-acetyl-
DON (1.48160.57 mg/kg), fumonisin B1 (0.70060.08 mg/kg),
fumonisin B2 (0.20160.02 mg/kg) and fumonisin B3
(0.20760.08 mg/kg). The adsorbing agent (illite-ambrosite clay)
was added in a concentration of 1.5 kg/ton feed. After three weeks
of feeding, the animals were euthanized and liver and intestinal
samples were immediately collected. From the small intestine,
samples were taken at three different locations: 2 cm after the
gizzard (duodenum), just before Meckel’s diverticulum (jejunum)
and two cm before the ileo-cecal transition (ileum). Intestinal and
liver samples were rinsed in phosphate buffered saline (PBS).
Afterwards, the samples for qRT-PCR analysis were immediately
frozen in liquid nitrogen and stored at 280uC until analysis.
Samples for morphological examination were also rinsed in PBS
and then fixed in 4% (v/v) phosphate buffered formalin.
Quantitative RT-PCR Method to Analyze the Intestinal
Barrier Function, Inflammation and Oxidative Stress
RNA from samples of liver and intestine (duodenum, jejunum
and ileum) were isolated using the SV Total RNA Isolation System
(Promega, Madison, WI, USA) according to the manufacturer’s
instructions, and total RNA was quantified by spectrophotometry
(Nanodrop ND-1000, Thermo Scientific, Wilmington, NC, USA).
Subsequently, 1 mg of extracted total RNA was reverse transcribed
with the iScriptTM cDNA Synthesis kit (Biorad, Hercules, CA,
USA). The obtained cDNA was diluted to a final concentration of
30 ng/mL. Primers were commercially produced (Eurogentec,
Nijmegen, the Netherlands) (Table 1). The primers used were
selected based on specificity and efficiency by qPCR analysis of a
dilution series of pooled cDNA at a temperature gradient (55uC to
65uC) for primer-annealing and subsequent melting curve analysis.
The reaction mixture for the qPCR containing 10 mL of the
diluted cDNA was mixed with 15 mL iQSYBR Green Supermix
(Biorad), forward and reverse primers (final concentration of
0.4 pmol/mL for each primer) and sterile water according to the
manufacturer’s instructions. qPCR was performed using the MyiQ
single-colour real-time PCR detection system (Biorad) and MyiQ
System Software Version 1.0.410 (Biorad). Amplification efficiency
was determined per plate using linregPCR. Data were analyzed
using the efficiency corrected Delta-Delta-Ct method [27].
Housekeeping genes were tested for all the test conditions after
which most stable housekeeping genes for liver and intestinal
samples were selected using the geNorm software (data not
shown). The most stable housekeeping genes had a M-value
between 0.2 and 0.5. To determine if the inclusion of an additional
housekeeping gene was required, the cut-off value for variation
was set at 0.2. The fold-change values of the genes of interest
(GOIs) were normalized using two housekeeping genes: hypoxan-
thine-guanine phosphoribosyl transferase (HPRT) and hexose-6-
phosphate dehydrogenase (H6PD). The mRNA expression of
proteins involved in oxidative stress i.e. HMOX, HIF-1a and
XOR were evaluated in the liver and intestine. Furthermore,
mRNA expression of the tight junctions proteins claudin 1 and 5
(CLDN1 and CLDN5) and zona occludens 1 and 2 (ZO1 and
ZO2) in sections from the duodenum, jejunum and ileum were
measured. Two compounds of the immune system, namely Toll-
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like receptors (TLR) 2 and 4 were also investigated during our
study. For the validation of the qPCR assays following criteria
were applied: slope between23.6 and23.1, efficiency between 90
and 110%, R2.0.99.
Morphological Examination of the Gut Wall
Formalin-fixed intestinal samples were dehydrated in xylene
and embedded in paraffin. With a microtome (Microm, Prosan,
Merelbeke, Belgium), sections of 4 mm thickness were cut and
mounted in glass slides. Afterwards, deparaffination occurred in
xylene (2 times 5 min) and then rehydratation occurred in
isopropylene (5 min), 95% alcohol (5 min) and 50% alcohol
(5 min). Sections were stained with haematoxylin and eosin. Using
light microscopy, villus height and crypt depth (10 villi per
intestinal segment) from each of 8 chickens per treatment, were
measured. For this, a Leica Camera DFC320 (Leica Microsystems
Ltd, Wetzlar, Germany) coupled to a computer-based image
analysis system LAS v.3.8. (Leica Microsystems Ltd) was used.
Only intact villi were measured. Measurements were done on
cross-sections of ring-shaped intestinal segments.
Data Analysis
Results were compared by ANOVA after determination of
normality and variance homogeneity. Multiple comparisons were
performed using a LSD post-hoc test. Not normally distributed
data were analyzed using the non-parametric Kruskal-Wallis
analysis, followed by a Mann-Whitney test using SPSS 19.0
Software (SPSS Inc., Chicago, IL, USA). A P-value of ,0.05 was
considered statistically significant.
Results
Not only DON but also the Adsorbing Agent Alters mRNA
Expression of Oxidative Stress Markers in Liver of Broiler
Chickens
In the liver, both HIF-1a and HMOX mRNA were significantly
down-regulated for all the broiler chickens receiving either DON,
an adsorbing agent or DON and the adsorbing agent, when
compared to the control group. Differently, XOR was significantly
up-regulated in the group receiving the DON contaminated feed.
The group receiving an adsorbing agent, whether or not in
combination with DON contaminated feed was not affected. Data
are shown in Figure 1.
DON Leads to Oxidative Stress in the Jejunum and in the
Ileum of Broiler Chickens in Combination with an
Adsorbing Agent
For the small intestine, the expression of HIF-1a, HMOX and
XOR mRNA was investigated in the duodenum, jejunum and
ileum. Expression of HIF-1a was unaltered in the intestine,
independently on the treatment or intestinal section. On the other
hand, HMOX and XOR were significantly up-regulated in the
jejunum of animals fed the DON contaminated feed, indepen-
dently on the supplementation of an adsorbing agent. For the last
Table 1. Primers used for the quantification of housekeeping genes (HKG) and genes of interest (GOI).
Gene Accession N6 Primer Sequence Product size (pb) Annealing T6
HKG
HPRT NM_204848.1 Forward 59 CGTTGCTGTCTCTACTTAAGCAG 39 90 65
Reverse 59 GATATCCCACACTTCGAGGAG 39
H6PD XM_425746.2 Forward 59 GGAGAACCAGCACTTCTTAGAC 39 84 64
Reverse 59 GGGTTCAGCAATTCCACTG 39
GOI
CLDN1 NM_001013611 Forward 59 CTGATTGCTTCCAACCAG 39 140 57–59
Reverse 59 CAGGTCAAACAGAGGTACAAG 39
CLDN5 NM_204201 Forward 59 CATCACTTCTCCTTCGTCAGC 39 111 56–65
Reverse 59 GCACAAAGATCTCCCAGGTC 39
HIF-1a NM_204297 Forward 59 CACCATTACCATACTTCAGCAG 39 88 65
Reverse 59 CTTCACATCATCCACACGTTC 39
HMOX NM_205344 Forward 59 CTTGGCACAAGGAGTGTTAAC 39 78 61–63
Reverse 59 CATCCTGCTTGTCCTCTCAC 39
TLR2 NM_204278 Forward 59 CCTGCAACGGTCATCTCAG 39 135 59
Reverse 59 GTCTCAGGGCTTGTTCTTCAG 39
TLR4 NM_001030693 Forward 59 CTGACCTACCCATCGGACAC 39 111 59
Reverse 59 GCCTGAGAGAGGTCAGGTTG 39
XOR NM_205127 Forward 59 GTGTCGGTGTACAGGATACAGAC 39 110 61
Reverse 59 CCTTACTATGACAGCATCCAGTG 39
ZO1 XM_413773 Forward 59 CTTCAGGTGTTTCTCTTCCTCCTC 39 131 59
Reverse 59 CTGTGGTTTCATGGCTGGATC 39
ZO2 NM_204918 Forward 59 CGGCAGCTATCAGACCACTC 39 87 64–65
Reverse 59 CACAGACCAGCAAGCCTACAG 39
doi:10.1371/journal.pone.0069014.t001
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part of the small intestine, the ileum, only XOR was up-regulated
when animals were fed with feed containing DON and the
adsorbing agent (Figure 2).
DON and Adsorbent do not Affect Duodenal Barrier
Function, but do so in Jejunum and Ileum
As observed for oxidative stress markers, barrier function of
duodenum was unaffected by both DON and adsorbing agent,
while jejunum presented a significant up-regulation of CLDN5
mRNA when animals were fed with DON contaminated feed.
Feed supplementation with the adsorbing agent did significantly
reduce the CLDN5 mRNA expression when compared to DON,
but its expression remained significant higher than that observed
in the control. The strongest effect on tight junctions was observed
in the ileum when animals were fed with feed contaminated with
DON and supplemented with the adsorbing agent, with a
significant up-regulation of CLDN1, CLDN5, ZO1 and ZO2
mRNA (Figure 2).
DON Leads to Inflammatory Reaction in Duodenum and
Jejunum, but its Negative Effect in the Ileum Depends on
the Feed Supplementation with an Adsorbing Agent
A significant up-regulation of TLR4 mRNA was observed in the
duodenum and jejunum of animals fed with DON contaminated
feed. Although feed supplementation with an adsorbing agent was
efficient to decrease the TLR4 expression, it was efficient to
recover control levels only in the duodenum and not in the
jejunum. Finally, as observed with tight junctions’ analysis, ileum
exposure to DON and adsorbing agent resulted in the significant
up-regulation of TLR4 mRNA (Figure 2).
Figure 1. Effects of DON and an adsorbent on oxidative stress
in the liver of broiler chickens. Results are presented as mean (6
SEM) mRNA expression. Fold change in gene expression levels of the
chicken liver relative to control group, which is considered 1. * Indicates
significant differences between treated and control animals.
doi:10.1371/journal.pone.0069014.g001
Figure 2. Effects of DON and an adsorbent on intestinal barrier in broiler chickens. Results are presented as mean (6 SEM) mRNA
expression. Fold change in gene expression levels of the chicken intestines relative to control group, which is considered 1. a–c Different lower-case
letters indicate significant differences between groups.
doi:10.1371/journal.pone.0069014.g002
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DON Alters the Gut Wall Morphology in Duodenum and
Jejunum of Broiler Chickens, but Addition of an
Adsorbing Agent Counteracts these Effects
Feeding DON contaminated feed resulted in a decreased villus
length and crypt depth both in duodenum and jejunum of the
broiler chickens. Addition of an adsorbing agent resulted in longer
villi, even in combination with DON and this over the entire
length of the small intestine. The crypt depth however, was not
influenced by the addition of an adsorbing agent to control feed in
the duodenum and jejunum, when compared to the control group.
On the other hand, the adsorbing agent had a positive effect on
the crypt depth in these intestinal parts, when added to DON
contaminated feed. In the ileum, no effect of feeding DON
contaminated feed without an adsorbing agent was observed. In
this part of the small intestine, it was the adsorbing agent in
combination with DON or not which resulted in higher villi and
deeper crypts (Table 2).
Discussion
Being an interface between the outside world and the inside
body, the gastro-intestinal tract (GIT) is a dynamic barrier [28].
This barrier is responsible for two major processes, which are on
the one hand uptake of nutrients and fluids and on the other hand
defense mechanism against xenobiotics. We performed a study
with broiler chickens fed with naturally contaminated feed to
investigate the effects of DON on the intestinal barrier and hepatic
function. Co-contamination of different mycotoxins in naturally
contaminated feed is common and this was also the case for the
experimental feed used in this study. DON was the most prevalent
mycotoxin and was even present in a concentration higher than
the European recommended maximum level of 5 mg/kg [29].
The other contaminant present, 3-acetylDON, is considered a
masked mycotoxin, i.e. a conjugated form of DON also produced
by Fusarium fungi. It is hypothesized that this conjugated form may
be hydrolysed and release DON in vivo, but the question remains
whether this occurs in every animal species and if this occurs
already in the GIT and/or liver and/or systemic circulation. The
sum of the concentration of the co-contaminants fumonisin B1 and
B2 of 0.901 mg/kg was much lower than the European guidance
value of 20 mg/kg in poultry feed [29]. Thus, the co-contamina-
tion with fumonisins can be considered as negligible. In our study,
three weeks feeding DON at 7.54 mg/kg feed reduced the villus
height and the crypt depth both in the duodenum and the
jejunum. Reduced villi in the duodenal and jejunal segment of the
small intestine were also observed in broiler chickens after 6 weeks
feeding a diet of 10 mg/kg DON [30]. Yunus et al. (2012)
observed a linear correlation between increasing levels of DON
and the decrease in villus height in both the mid-duodenum and
mid-jejunum [31]. Possible explanation for these histological
changes can be a direct irritant effect of the mycotoxin or
suppression of mitosis or protein synthesis [18,31]. In order to
maintain an effective barrier function, the intestinal epithelium
needs to regenerate continuously. Mature cells migrate along the
crypt-villus axis towards the villus-top, in the mean time these cells
become differentiated cells [32]. DON can be responsible for a
reduced cell proliferation [33–35]. This can be an explanation for
the reduced crypt depth observed during our trial. A decreased
crypt depth in the mid-duodenum in broiler after chronic exposure
to DON (12 mg/kg) has been reported earlier [31]. Interestingly,
the adsorbing agent resulted in longer villi over the entire length of
the small intestine. These longer villi seen in our study in the
chickens receiving the adsorbing agent, can be responsible for the
higher oral bioavailabilities of xenobiotics as observed in our
previous study [12].
Several studies both in vitro and in vivo already reported that
DON is able to alter intestinal permeability. Intestinal physiology
can even be affected by DON in the absence of clinical signs [36].
The function of the tight junctions can be evaluated by
measurements of the transepithelial electrical resistance (TEER)
and of the paracellular efflux of macromolecules [37]. These
techniques, however, do not give information which specific
protein of the tight junctions is affected [38]. Therefore, a qRT-
PCR method was applied in our study to evaluate the effects of
DON on the different specific proteins of the tight junctions,
namely CLDN1, CLDN5, ZO1 and ZO2. An important
advantage of this technique is the generation of quantitative
results, which makes it possible to detect small differences which
could otherwise be missed when using immunofluorescence.
Moreover, due to the lack of suitable commercial avian antibodies,
no effects at the protein level could be studied. This general lack in
anti-chicken antibodies for use in Western blot and immunoflu-
orescence is well known in poultry research.
Major effects of feeding DON without an adsorbing agent on
the intestinal barrier were observed in the jejunum. A significant
up-regulation of CLDN5 was observed in the jejunum of the
groups fed contaminated feed with or without an adsorbing agent.
No significant differences were noticed in the jejunum for the
mRNA expression of the other genes coding for the intestinal
barrier function. The ileum on the other hand, is less susceptible to
DON due to the fact that the majority of ingested DON is
absorbed in the proximal parts of the small intestine [39].
However, in the group receiving DON in combination with an
adsorbing agent, detrimental effects were seen in the ileum. This
indicates that addition of the adsorbing agent results in a sustained
presence of DON in the intestine.
The results of our study suggest that DON selectively acts on the
different parts of the tight junction complex as only an up-
regulation of CLDN5 was observed. A selective effect of DON has
been observed in vitro in intestinal porcine epithelial cells and
human Caco-2 cells. After 48 h exposure to DON at a
concentration of 9000 ng/mL both claudin 3 and 4 showed
Table 2. Length of villi (mm) and crypt depth (mm) in
duodenum, jejunum and ileum after 3 weeks feeding a
control diet or feed contaminated with DON, either or not
supplemented with an adsorbing agent. Results are presented
as mean values and standard deviations of fifteen villi or
crypts measured from 8 chickens per treatment group.
Control
Adsorbing
agent DON
DON+
adsorbing
agent
Duodenum
Villus height 1734626a 1773643c 1449631b 1789639c
Crypt depth 13167a 13467a 11469b 12868a
Jejunum
Villus height 1343637a 1521639c 1184648b 1509643c
Crypt depth 12068a 116610a 10168b 10967c
Ileum
Villus height 596630a 773663b 616638a 744663b
Crypt depth 11366a 124617b 110615a 119618ab
a,b mean values within a row with unlike superscript letters are significantly
different (p#0.05).
doi:10.1371/journal.pone.0069014.t002
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reduced protein expression, but ZO1 and occludin were not
affected [40]. The same authors also described a reduced claudin 4
expression in growing pigs after in vivo exposure to DON (2.85 mg
DON/kg feed) for 5 weeks, using Western blot analysis and
immunohistochemistry. Immunohistochemistry results showing no
changes in the overall morphology of the cells, but only a
decreased staining for the claudins, strengthens our hypothesis of a
selective action of DON [40]. Selective action of DON on claudin-
isoforms was confirmed in other more recent in vitro studies
[41,42]. Our study is, to our knowledge, the first one showing the
effects of DON on the intestinal barrier in poultry after in vivo
exposure to DON.
Different authors also suggest that trichothecenes may be
responsible for the production of free radicals, causing damage to
DNA and membranes and thus suggesting that oxidative stress
may play an important role in their toxicity [43–47]. Up-
regulation of HIF-1a often occurs in the first hours of hypoxia
and, thereafter, returns to basal levels. This can be an explanation
for the basal levels of HIF-1a found in the small intestine during
this study. However, instead of basal expression of HIF-1a, we
have observed its down-regulation in the liver of chicken, after
exposure to DON or the adsorbing agent alone or in combination.
As shown recently by Sparkenbaugh et al. (2011) [48], HIF-1a is
up-regulated during liver injury in the initial phase of inflamma-
tion and oxidative stress, and should guarantee cell protection
when the stress becomes chronic, which was not observed in our
study. Furthermore, protection against hepatocyte death is related
to the up-regulation of HMOX [21]. In our present study,
however, hepatic HMOX was also significantly down-regulated in
animals fed with adsorbent supplemented feed, contaminated with
DON, or with a combination of both. In contrast, in the jejunum a
significant up-regulation of HMOX was observed in the animals
receiving DON contaminated feed with or without the adsorbing
agent. XOR, which responds more in the chronic phase, was
significantly up-regulated in the jejunum in all the animals
receiving DON, but in the liver an up-regulation was observed
only in the group receiving DON without an adsorbing agent. In
summary, DON caused oxidative stress in the small intestine. This
has previously been reported in Caco-2 cells, where DON caused
a significantly increased production of malondialdehyde, a
biomarker of lipid peroxidation [49]. The hepatic effects of in vivo
exposure to 10 mg/kg DON in broiler chickens have previously
been reported by Frankic et al. (2006). They observed no
differences in liver content of malondialdehyde, glutathione
peroxidase and total antioxidant status, which are all markers
for lipid peroxidation [50]. These findings suggest a more direct
genotoxic effect of DON, rather than via the oxidative pathway
[51,52].
Due to the damage to the intestinal barrier, an increased
passage of non-invasive commensal bacteria may occur [53]. Both
in duodenum and jejunum a significant up-regulation of TLR4
was observed during our study, which suggests inflammation,
more specific due to the presence of Gram-negative bacteria [54].
In contrast, no effects on TLR2 were observed. TLR2 is more
affected by the presence of Gram-positive bacteria [55].
In the last part of the small intestine, the ileum, inflammation
was caused by the presence of DON in combination with the
adsorbing agent. In addition, in this group all the genes coding for
the tight junction complex were also up-regulated and the same
trend was observed for the gene XOR, coding for oxidative stress.
Along the entire length of the small intestine administration of the
adsorbing agent resulted in longer villi. From our qRT-PCR
results, we can conclude that it is not the adsorbing agent that
causes damage as no significant differences in gene expression
were seen in the group receiving control feed in combination with
the adsorbing agent. The adsorbing agent is a mineral clay and
seems to protect DON from degradation by the gastric fluids and
intestinal enzymes in the proximal part. This may result in a
higher concentration of the mycotoxin in the distal part of the
small intestine when an adsorbing agent is used. Thus the binding
or interaction of DON with the adsorbing agent results in a longer
exposure time of the intestine to DON.
From our in vivo study, we can conclude that DON acts in a very
specific way on the intestinal barrier in broiler chickens. Increased
intestinal barrier permeability after chronic exposure to DON may
lead to intestinal inflammation. The mechanism of action of DON
can be different depending on the investigated target organ. The
investigated mycotoxin adsorbing agent does not cause direct
damage or irritation. However, feeding this clay mineral in
combination with DON, may result in higher concentrations of
the mycotoxin in more distal parts of the small intestine, resulting
in damage of the intestinal barrier there.
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